(Q40672537)
Statements
Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies? (English)
Kuus-Reichel K
Grauer LS
Karavodin LM
Knott C
Krusemeier M
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference